Bowman & Co S.C.: ADI position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bowman & Co S.C. on ADI, newest first. How the timeline and the estimate are built.
Bowman & Co S.C. held 10,286 ADI shares at 2025-12-31 per its 13F-HR filed 2026-01-23.
the latest 13F is the newest step
- period ended2025-12-3113F 10,286 sharesChange vs previous 13F +260 shares
1.18% of the 13F portfolio, value $2,792,572.
13F-HR 0002085853-26-000074 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 10,026 sharesChange vs previous 13F +3,351 shares
1.04% of the 13F portfolio, value $2,465,702.
13F-HR 0002085853-25-000056 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 6,675 sharesChange vs previous 13F -773 shares
0.71% of the 13F portfolio, value $1,591,425.
13F-HR 0001667731-25-000756 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 7,448 sharesChange vs previous 13F +1,471 shares
0.74% of the 13F portfolio, value $1,503,877.
13F-HR 0001667731-25-000377 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 5,977 sharesChange vs previous 13F -1,028 shares
0.66% of the 13F portfolio, value $1,272,041.
13F-HR 0001667731-25-000035 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 7,005 sharesChange vs previous 13F not available
0.85% of the 13F portfolio, value $1,614,824.
13F-HR 0001906275-24-000004 filed by Bowman & Co S.C.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).